Skip to main content

Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.

Publication ,  Journal Article
Mathew, RO; Maron, DJ; Anthopolos, R; Fleg, JL; O'Brien, SM; Rockhold, FW; Briguori, C; Roik, MF; Mazurek, T; Demkow, M; Malecki, R; Ye, Z ...
Published in: Circ Cardiovasc Qual Outcomes
October 2022

BACKGROUND: Patients with chronic kidney disease (CKD) on dialysis (CKD G5D) have worse cardiovascular outcomes than patients with advanced nondialysis CKD (CKD G4-5: estimated glomerular filtration rate <30 mL/[min·1.73m2]). Our objective was to evaluate the relationship between achievement of cardiovascular guideline-directed medical therapy (GDMT) goals and clinical outcomes for CKD G5D versus CKD G4-5. METHODS: This was a subgroup analysis of ISCHEMIA-CKD (International Study of Comparative Health Effectiveness With Medical and Invasive Approaches-Chronic Kidney Disease) participants with CKD G4-5 or CKD G5D and moderate-to-severe myocardial ischemia on stress testing. Exposures included dialysis requirement at randomization and GDMT goal achievement during follow-up. The composite outcome was all-cause mortality or nonfatal myocardial infarction. Individual GDMT goal (smoking cessation, systolic blood pressure <140 mm Hg, low-density lipoprotein cholesterol <70 mg/dL, statin use, aspirin use) trajectory was modeled. Percentage point difference was estimated for each GDMT goal at 24 months between CKD G5D and CKD G4-5, and for association with key predictors. Probability of survival free from all-cause mortality or nonfatal myocardial infarction by GDMT goal achieved was assessed for CKD G5D versus CKD G4-5. RESULTS: A total of 415 CKD G5D and 362 CKD G4-5 participants were randomized. Participants with CKD G5D were less likely to receive statin (-6.9% [95% CI, -10.3% to -3.7%]) and aspirin therapy (-3.0% [95% CI, -5.6% to -0.6%]), with no difference in other GDMT goal attainment. Cumulative exposure to GDMT achieved during follow-up was associated with reduction in all-cause mortality or nonfatal myocardial infarction (hazard ratio, 0.88 [95% CI, 0.87-0.90]; per each GDMT goal attained over 60 days), irrespective of dialysis status. CONCLUSIONS: CKD G5D participants received statin or aspirin therapy less often. Cumulative exposure to GDMT goals achieved was associated with lower incidence of all-cause mortality or nonfatal myocardial infarction in participants with advanced CKD and chronic coronary disease, regardless of dialysis status. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT01985360.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

October 2022

Volume

15

Issue

10

Start / End Page

e008995

Location

United States

Related Subject Headings

  • Renal Insufficiency, Chronic
  • Renal Dialysis
  • Myocardial Infarction
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Cholesterol, LDL
  • Cardiovascular System & Hematology
  • Aspirin
  • 4206 Public health
  • 3201 Cardiovascular medicine and haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mathew, R. O., Maron, D. J., Anthopolos, R., Fleg, J. L., O’Brien, S. M., Rockhold, F. W., … Bangalore, S. (2022). Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circ Cardiovasc Qual Outcomes, 15(10), e008995. https://doi.org/10.1161/CIRCOUTCOMES.122.008995
Mathew, Roy O., David J. Maron, Rebecca Anthopolos, Jerome L. Fleg, Sean M. O’Brien, Frank W. Rockhold, Carlo Briguori, et al. “Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.Circ Cardiovasc Qual Outcomes 15, no. 10 (October 2022): e008995. https://doi.org/10.1161/CIRCOUTCOMES.122.008995.
Mathew RO, Maron DJ, Anthopolos R, Fleg JL, O’Brien SM, Rockhold FW, et al. Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circ Cardiovasc Qual Outcomes. 2022 Oct;15(10):e008995.
Mathew, Roy O., et al. “Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial.Circ Cardiovasc Qual Outcomes, vol. 15, no. 10, Oct. 2022, p. e008995. Pubmed, doi:10.1161/CIRCOUTCOMES.122.008995.
Mathew RO, Maron DJ, Anthopolos R, Fleg JL, O’Brien SM, Rockhold FW, Briguori C, Roik MF, Mazurek T, Demkow M, Malecki R, Ye Z, Kaul U, Miglinas M, Stone GW, Wald R, Charytan DM, Sidhu MS, Hochman JS, Bangalore S. Guideline-Directed Medical Therapy Attainment and Outcomes in Dialysis-Requiring Versus Nondialysis Chronic Kidney Disease in the ISCHEMIA-CKD Trial. Circ Cardiovasc Qual Outcomes. 2022 Oct;15(10):e008995.

Published In

Circ Cardiovasc Qual Outcomes

DOI

EISSN

1941-7705

Publication Date

October 2022

Volume

15

Issue

10

Start / End Page

e008995

Location

United States

Related Subject Headings

  • Renal Insufficiency, Chronic
  • Renal Dialysis
  • Myocardial Infarction
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Humans
  • Cholesterol, LDL
  • Cardiovascular System & Hematology
  • Aspirin
  • 4206 Public health
  • 3201 Cardiovascular medicine and haematology